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Patent Litigation in Europe— A Glimmer of Hope?
Present Status and Future Perspectives*
Joseph Straus**
I. THE POTENTIAL FOR PATENT LITIGATION IN
THE EUROPEAN UNION
When looking at the number of patent applications filed and the
number of patents issued since the adoption of the Convention on the
Grant of European Patents (European Patent Convention— EPC) in
1973 and its entry into force in 1977,1 the EPC must be viewed as a
success story. During the EPC’s first one and one-half years of
operation from June 1, 1978 through December 31, 1979,
applications filed totalled 15,151.2 This figure was 82,870 for 1998
with 1,177,256 designations.3
By the end of 1998, 443,775 total European patents had been
issued, with designations in the last few years anually exceeding the
mark of 270,000.4 The future increase of European patent
* Slightly amended text of the Katz-Kiley Lecture given at the University of Houston
Law Center on November 3, 1999
** J.D., Professor of Law, Universities of Ljubljana and Munich, Head of Department,
Max-Planck Institute for Foreign and International Patent, Copyright and Competition Law,
Munich.
1. EPO O.J. 6 (1977).
2. EPO O.J. 257 (1979).
3. 1998 EPO ANN. REP. 55. The membership in the EPC increased from 7 to 19
Contracting States in 1998: Austria, Belgium, Cyprus, Denmark, Finland, France, Germany,
Greece, Ireland, Italy, Liechtenstein, Luxembourg, Monaco, the Netherlands, Portugal, Spain,
Sweden, Switzerland, and the United Kingdom; cf. EPO O.J. 240 (1999). Moreover, so-called
extension agreements exist between the European Patent Organization and the following states:
Albania, Latvia, Lithuania, Romania, Slovenia, and the Former Yugoslav Republic of
Macedonia; cf. EPO O.J. 241 (1999). In 1998 the number of extension requests for these
countries passed the 10,000 mark for the first time— in 1997 it was 7,000; cf. 1998 EPO ANN.
REP. 33.
4. 3. Untersuchung von Urteilen der Nichtigkeitssenate des Bundespatentgerichts und
von Urteilen des X. Senats des Bundesgerichtshofs [BGH], Table at 2 (July 1999); 1998 EPO
ANN. REP. 55, 63.
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applications filed and European patents issued can be reasonably
predicted.5 Bulgaria, the Czech Republic, Estonia, Hungary, Poland,
Romania, Slovakia, and Slovenia are invited to accede to the
European Patent Convention (EPC) by July of 2002.6 The EPC will
then have twenty-seven Contracting Parties. In view of these facts,
little imagination is needed to realize the magnitude of the potential
for European patents’ validity and infringement litigation in the
fifteen Member States of the European Union.
II. PRESENT STATUS OF PATENT LITIGATION IN EUROPE
A. The EPC’s Basic Scheme of Operation
According to article 2(2) of the EPC, a European patent has, in
each of the Contracting States for which it is granted, the same effect
and is subject to the same conditions as a national patent granted by
that state, unless otherwise provided in the EPC. In particular, it
confers on the patentee the same rights as those conferred by a
national patent granted in that state (article 164(1) of the EPC).
Nonetheless, the EPC, with its article 69 rule on the extent of
protection, imposes on all courts the necessity of construing the
national patents in the same way.7
Article 69 should not be interpreted in the sense that the extent
of the protection conferred by a European patent is to be
understood as that defined by the strict, literal meaning of the
wording used in the claims, the description and drawings being
employed only for the purpose of resolving an ambiguity
5. In 1999 the number of applications increased dramatically to some 122,000, of which
59% were Euro-PCT applications. The number of extension requests in 1999 was around
15,000, which represented a rise of about 50% (see Report of the Administrative Council of the
European Patent Organization on the 78th mtg. (Dec. 7 and 8, 1999), 2000 EPO O.J. 41).
6. 1998 EPO ANN. REP. 33.
7. Article 69(1) of the EPC reads as follows:
The extent of the protection conferred by a European patent or a European patent
application shall be determined by the terms of the claims. Nevertheless, the
description and drawings shall be used to interpret the claims.” In order to ensure a
harmonized application of article 69(1) of the EPC, the Contracting States agreed on
the Protocol on the Interpretation, which forms an integral part of the Convention
pursuant to article 164(1) of the EPC.
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found in the claims. Neither should it be interpreted in the
sense that the claims serve only as a guideline and that the
actual protection conferred may extend to what, from a
consideration of the description and drawings by a person
skilled in the art, the patentee has contemplated. On the
contrary, it is to be interpreted as defining a position between
these extremes which combines a fair protection for the
patentee with a reasonable degree of certainty for third parties.8
Mr. Justice Laddie of the UK High Court of Justice therefore
correctly observed that national patent rights based on European
patents “[c]an be considered as cuttings from the European stock and
planted in the national soil.”9 Article 138 of the EPC sets forth the
only grounds under which a European patent may be revoked under
the law of a Contracting State with an effect on its territory.
Eventually, in article 64(3) of the EPC it is clarified that any
infringement of a European patent should be dealt with using national
law, whether it is procedural or substantive law.10 It must be added
that in this context, however, the cuttings of the European patent
stock in national soil may, and often does, lead to different or even
contradicting results when identical clones are tested in national
courts for infringement or validity. The well known case of the so-
called “Epilady” patent serves as a prominent example.11
The fact is that the national patents out of the European patent
bundle exist independently of each other. It is therefore quite
possible for one national patent out of the European bundle to
be declared wholly or partially null and void while another is
held to be valid. It is moreover not impossible that the scope of
protection of one patent turns out to be different from that of
the other one.12
8. Id.
9. In re Coin Limited v. Suzo International (U.K.) Limited et al., [1997] F.S.R. 660, 672.
10. Cf. Singer/Lunzer, The European Patent Convention— A Commentary, No. 64-06
(London 1995).
11. Cf., e.g. Epilady VII [1993] G.R.U.R. at 242 (Int.); Epilady XII [1993] G.R.U.R. at
252 (Int.); Epilady U.K [1990] 21 App. Cas. at 561 (I.I.C.). See also the respective discussion in
Expandable Grafts Partnership v. Boston Scientific B.V. [1999] F.S.R. 352, 358 (No. 18 s.).
12. Id.
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Doubts, which might have existed regarding the jurisdiction in
proceedings concerning the registration or validity of European
patents, have been removed by article Vd of the Protocol to the
Convention on Jurisdiction and the Enforcement of Judgements in
Civil and Commercial Matters of 1968 (Brussels Convention).
Article Vd was added by the 1978 Accession Convention.13 It
provides for exclusive jurisdiction of the courts of each Contracting
State for any European patent granted for that state, regardless of
domicile of the defendant and without prejudice to the jurisdiction of
the EPO under the EPC. In other words, the designation of an EPC
Contracting State in a European patent application and the grant of a
European patent, followed by registration for that state and not the
place of filing the application as provided for in article 16(4) of the
Brussels Convention, is deemed the exclusive jurisdiction in
proceedings concerning the registration or validity of European
patents, trademarks, designs, or other similar rights requiring deposit
or registration. In the absence of article Vd of the 1978 Protocol, one
may assume the jurisdiction of German Courts under article 16(4) of
the Brussels Convention, because Munich is the seat of the EPO and
the place where applications for European patents are filed.14
However, the general rules of the Brussels Convention are to be
applied in proceedings concerning the infringement of European
patents.15 In this context one must realize that strict separation of
validity and infringement proceedings is practically impossible
whenever both are in issue. Thus, in principle, validity and
infringement of a patent may be tried by the same court. This is true
because “[w]here questions of infringement and validity both arise it
is invariably not possible to conclude there is infringement without
13. 1978 EC O.J. (L 304) 1.
14. Cf. Prof. Schlosser, Report on the Convention on the Association of the Kingdom of
Denmark, Ireland and the United Kingdom of Great Britain and Northern Ireland to the
Convention on Jurisdiction and the Enforcement of Judgements in Civil and Commercial
Matters and to the Protocol of its Interpretation by the Court of Justice, No. 173 (Oct. 9, 1978),
reproduced inter alia in: A. DASHWOOD ET AL., A GUIDE TO THE CIVIL JURISDICTION AND
JUDGEMENTS CONVENTION 399, 451 (1987), and WADLOW, ENFORCEMENT OF INTELLECTUAL
PROPERTY IN EUROPEAN AND INTERNATIONAL LAW, No. 2-130, 2-131 (London 1998).
15. For details, see Kieninger, Internationale Zuständigkeit bei der Verletzung
ausländischer Immaterialgüterrechte: Common Law auf dem Prüfstand des EuGVÜ, 1999
G.R.U.R. INT. 280, 281 (with numerous further references). See also infra note 9.
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validity being determined.”16 The issue of validity will normally be
the principal element of the dispute.17
In this context it should be added that, when applying article 138
of the EPC, courts of the EPC Contracting States have revoked
European patents for the same reasons articulated in the opposition
by the European Patent Office. This is also true of state of the art,
which had already been considered by the EPO Examination and
Opposition division. Those conclusions are viewed as non-binding
for the courts when deciding on nullity pursuant to article 138 of the
EPC.18 Depending on the national patent law provisions of the EPC
Contracting States, actions for the revocation of European patents
before national courts may be initiated even before the opposition
proceedings have come to an end in the European Patent Office.19
B. Difficult Fact Finding
It is true, but difficult to believe, that at the present time
comprehensive and reliable information on the numbers and nature of
cases litigated involving validity or infringement of European patents
in the 19 EPC Contracting States is not available. So far, even the
efforts of the European Patent Office have provided only limited data
for France, Germany and the Netherlands.
In Germany, as in Austria, validity and infringement are tested by
different courts or judicial bodies. The Federal Patent Court had
exclusive jurisdiction over validity from 1983 to 1997, during which
16. Fort Dodge Animal Health Ltd. v. Akzo Nobel N.V. [1998] F.S.R. 222, at 243;
Expandable Grafts Partnership v. Boston Scientific B.V., [1999] F.S.R. 352, 361.
17. Cf. Fort Dodge Animal Health Ltd. v. Akzo Nobel N.V., [1998] F.S.R. 244.
18. Cf., e.g., German Federal Supreme Court (BGH), Bogensegment 1996 G.R.U.R. 862,
at 864; Zahnkranzfräser [1996] G.R.U.R. 56 (int.); Regenbecken [1998] G.R.U.R. 895
(explicitly followed in Bühler AG v. Chronos Richardson Ltd. [1998] R.P.C. 609, 618 (Aldous,
L.-J.). Cf. also the previous UK cases referred to by Lord Justice Aldous, ibidem, at 610, as
well as Biogen Inc. v. Medeva Plc., [1997] R.P.C. 1.
19. Cf. Beloit Technologies Inc. v. Valmet Paper Machinery Inc. [1997] R.P.C. 489, 503.
Because of the lengthy opposition proceedings in the EPO, which take from about 4-8 years,
British Courts are also not inclined to stay the English proceedings pending a final resolution of
the European proceedings. Cf. also G.D. Harris, Analysis: The Patents Court and the EPO—
The Ultimate Mixed Message, 1999 I.P.Q. 250, 251, reporting on “notorious delays in the
appeals procedure in the EPO which have been known to result in delays of up to 14 years in
the resolution of issues,” id. at 251.
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time 462 nullity actions were filed. This represents 1.2% of all
389,684 European patents issued with the designation of Germany,
(or 95.7% of all EP’s). Of those 462 suits, 202 were withdrawn, and
67 are still pending. Of the remaining 193 cases that ended with a
decision on the merits, 42 (31%) of the European patents were
declared valid, 56 (42%) were partly invalid, 35 (26%) were invalid,
and one was surrendered.20
For the Netherlands, where the Hague Courts have exclusive
jurisdiction over patent cases involving validity and infringement,
statistics reveal that, for the period from 1993 to 1997, 129 actions
were filed involving European patents. Of those cases, 30 ended
without a decision on the merits. Of the remaining 99, only 57
explicitly or implicitly dealt with validity. Of those, 44 were held
valid, 4 were held partly invalid, and 9 were held invalid.21
Data available for France for the period from 1986 to 1997
indicates a total of 61 cases involving European patents. Of those
cases, 25 were not related to either validity or infringement, and in 5
others validity was not challenged. Of the 29 patents tested, 18 were
held valid, 6 were held partly invalid and 5 were held invalid.22 Data
on hearings in the United Kingdom Patent Court are available;
however, the data cannot be reliably classified. The number of cases
tried during the 1998-1999 year is assumed to be less than 100. A
very rough, unofficial estimate by the EPO is that some 600 court
actions are filed per year in the Contracting States that have in issue
the validity or infringement of European patents.
C. The Thorny Life under the Brussels (and Lugano) Convention
As already indicated above, the jurisdiction for litigating validity
and infringement of European patents is largely controlled by the
Brussels and corresponding Lugano Convention.23 It would exceed
20. See supra note 4.
21. EPO Internal Doc. (Nov. 5, 1997).
22. EPO Internal Doc. (Nov. 5, 1997).
23. See supra note 3. The Lugano Convention on Jurisdiction and the Enforcement of
Judgements in Civil and Commercial Matters of 1988 by and large corresponds to the Brussels
Convention. It has extended the area of application to all states then Members of the European
Economic Area. 1998 O.J. (L 319).
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my task to attempt to provide more than a brief presentation of the
basic mechanisms of the Brussels Convention for adjudicating patent
disputes, including the most recent application by courts of some
EPC Contracting States. The only aim of this exercise is to
demonstrate, as far as possible, the weakness of the entire system.
This weakness is due to the fact that the Union is still lacking not
only the Community patent, but also many of its indispensable
attributes, which were provided for under the Council Agreement
relating to Community patents; inter alia, the system provided for
patent litigation under the Protocol on Litigation.
Prior to addressing the basic principles of the Brussels Convention
controlling patent litigation, it seems necessary to consider its very
aims. In Duijnstee v. Goderbauer the European Court of Justice
(ECJ) circumscribed these aims as follows:
[A]ccording to the preamble to the Convention, the
Contracting States, anxious to “strengthen in the Community,
the legal protection of persons therein established,” considered
that it was necessary for that purpose “to determine the
international jurisdiction of their courts, to facilitate
recognition and to introduce an expeditious procedure for
securing the enforcement of judgements, authentic instruments
and court settlements.”24
Both the provisions on jurisdiction and those on the recognition and
enforcement of judgements are therefore aimed at strengthening the
legal protection of persons established in the Community.25 As
pointed out in Effer v. Kantner:
 [t]he Convention provides a collection of rules which are
designed inter alia to avoid the occurrence, in civil and
commercial matters, of concurrent litigation in two or more
Member States and which, in the interests of legal certainty
and for the benefit of the parties, confer jurisdiction upon the
24. Duijnstee v. Goderbauer, [1983] E.C.R. 3663, 3674-75 (Case 288/82).
25. Id.
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national court territorially best qualified to determine a
dispute.26
As the ECJ has pointed out, it is not the object of the Convention to
unify the rules of substantive law and the procedures of the different
Contracting States.27
As the headings of the respective Sections reveal, the Brussels
Convention differs regarding its rules on jurisdiction. On the one
hand, the general rule adopted in article 2 is that defendants
domiciled in a Contracting State are to be sued in courts of their state
of domicile. On the other hand, the special jurisdiction of Section 2,
by way of derogation from that general principle of the Convention,
confers in article 5(3) that “in matters relating to tort, delict or quasi-
delict” jurisdiction is conferred on the courts in the place where the
harmful event occurred. Article 6(1) provides another special
jurisdiction: a defendant, who is one of a number of defendants, may
be sued in the State where any one defendant is domiciled.
It is established case law of the ECJ that the “special jurisdiction”
enumerated in articles 5 and 6 of the Convention, as derogation from
the general principle that jurisdiction is vested in the Courts of the
State of defendants’, must be interpreted restrictively.28 Without
going into details regarding the interpretation of the complex
expression “place where the harmful event occurred” in article 5(3)
of the Convention, it should be pointed out that in construing the
proper Convention of that expression, the ECJ in Mines de potasse de
l’Alsace held that the expression encompasses both “[t]he place
where the damage occurred and the place of the event giving rise to
it.”29 In Dumez France and Tracoba the ECJ further pointed out that
the jurisdictional rule contained in article 5(3) supports the need for a
close connecting factor between the dispute and the Court hearing the
case, i.e., the need for sound administration of justice.30 Finally, in
26.  [1982] E.C.R. 825 (Case 38/81).
27. Case C-365/88, Hagen v. Zeehaghe, 1990 E.C.R. I-1845,.
28. Case 189/87, Anthanasios Kalfelis v. Bankhaus Schröder, Münchmeier, Hengst & Co.
1988 E.C.R. 5565; see also Case C-26/91, Handte, 1992 E.C.R. I-3967 Case C-68/93, Fiona
Shevill v. Press Alliance SA, 1995 E.C.R. I-415.
29. Case 21/76, 1976 E.C.R. 1735.
30. Case C-220/88, 1990 E.C.R. I-49.
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Kalfelis the Court held “. . . [t]hat a court which has jurisdiction
under article 5(3) over an action in so far as it is based on tort or
delict does not have jurisdiction over that action in so far as it is not
so based.”31
From case law of the ECJ Advocate General, Darmon draws the
conclusion in Shevill v. Press Alliance that the Court of one
contracting state where the damage arose cannot hear proceedings for
compensation for damage arising in other Contracting States because
there is no element of proximity connecting the forum with the
dispute. Courts in the place where the damage arises are best placed
to access the harm done to the victims’ reputations within their
judicial districts and to determine the extent of the damage. The
adoption of such a criterion avoids the occurrence of concurrent
litigation in different forums, since the compensation for each of
them is restricted to the damage arising within their respective
judicial districts.32 The ECJ eventually answered the respective
questions referred to by the House of Lords in Shevill v. Press
Alliance that:
[o]n a proper construction of the expression “place where the
harmful event occurred” in article 5(3) of the Convention, the
victim of a libel by a newspaper article distributed in several
Contracting States may bring an action for damages against the
publisher either before the Courts of the Contracting State of
the place where the publisher of the defamatory publication is
established, which have jurisdiction to avoid damages for all
the harm caused by the defamation, or before the courts of
each Contracting State in which the publication was distributed
and where the victim claims to have suffered injury to his
reputation, which have jurisdiction to rule solely in respect of
the harm caused in the state of the court seised.33
31. [1988] E.C.R. 5565.
32. [1995] E.C.R. I-431.
33. [1995] E.C.R. I-462, and operative part, I-465. Following the principles developed by
the ECJ, the Court of First Instance of Düsseldorf denied its jurisdiction under article 5(3) of
the Brussels Convention for adjudicating an infringement of the Belgium part of a European
patent of an Italian patentee by a Belgium domiciled defendant in Belgium, who had at the
same time potentially infringed the German part of the European patent at hand. So far only the
Washington University Open Scholarship
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With regard to the application of the co-defendant rule of article
6(1) of the Brussels Convention, it is important to note that the ECJ
in Kalfelis v. Bankhaus Schröder inter alia held that:
[f]or Article 6(1) of the Convention to apply there must exist
between various actions brought by the same plaintiff against
different defendants a connection of such a kind that it is
expedient to determine those actions together in order to avoid
the risks of irreconcilable judgements resulting from separate
proceedings.34
It follows from this, and from the necessity to apply article 6(1)
restrictively, that the choice to sue defendants from different
Contracting States for infringement of parallel patents arising in
different Contracting States in one court is limited. Article 6(1) may
apply if the defendants form part of the same group of companies,
sold identical products in national markets of the Contracting States,
and there was some “taking part” in “the common design” by
defendants.35 Under these circumstances, simultaneous hearings and
settlement of all the actions would be covered by article 6(1) of the
Brussels Convention. Affirming in principle such a possibility,
however, does not answer the question of how to prevent the plaintiff
in such circumstances from engaging in forum shopping, which the
Convention tries to prevent. An analogy with article 5(3) and the case
law handed down under it by the ECJ36 led the Hague Court of
Appeals to the conclusion that all the actions had to be brought in the
jurisdiction for the infringement of the German part in Germany has been affirmed (in
Schußfadengreifer [1999] G.R.U.R. 455 (Int.)). With reference to the ECJ Marinari v. Lloyd’s
Bank plc and Zubaidi Trading Co. decision (Case C 364/93, 1995 E.C.R. I-2719), the
Düsseldorf Court also stated that the place where a consequential damage occurred does not
establish jurisdiction under article 5(3) of the Brussels Convention (Id. at 457-58).
34. Case 189/8, 1988 E.C.R. 5565.
35. Cf. Unilever Plc. v. Chefaro Properties Ltd., [1994] F.S.R. 135, 139-41, where L.J.
Glidewell stated:
In order to show infringement by common design, it is necessary for the plaintiff to
show some act of the common design— not merely an agreement. The issue, therefore,
before the judge and this court is: does the evidence show a good arguable case that
there was such a common design and/or that Akzo had procured or assisted Chefaro to
infringe.
36. See supra notes 11-13.
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jurisdiction where the head office of the group of defendants or the
office from which the business plan originated, the so-called “spider
in the web,” was domiciled.37
The already reported exclusive jurisdiction under article 16(4) is
of utmost importance for the application of the Brussels Convention
to patent litigation. Article 16(4), in connection with article Vd of the
1978 Protocol in proceedings concerned with the registration or
validity of a European patent, provides exclusive jurisdiction to the
courts of the EPC Contracting States for which that patent was
granted.38 In order to ensure that subject matter of exclusive
jurisdiction will be heard only in competent courts under the rule set
forth in article 19 of the Brussels Convention, a court seised of a
claim that is principally concerned with a matter falling within
exclusive jurisdiction of the courts of another Contracting State must
deny its jurisdiction on its own motion. The issue immediately arises
as to what is meant by “principally concerned.” In view of the
practically indissoluble link between validity and infringement in
patent litigation,39 in which the first is without exception a pre-
condition of the second and is easy to decide, it is not very helpful
that preliminary or incidental dealing with a matter which falls into
exclusive jurisdiction of the courts of another Contracting State
should not oblige a court to deny jurisdiction.40
Mention should also be made that the Brussels Convention, in
order to prevent parallel proceedings before the courts of different
Contracting States and to avoid conflicts between decisions that
might result, provides for a lis pendens rule in article 21.41 Under that
rule, any court other than the court first seised with the same cause of
action between the same parties shall, of its own motion, stay its
proceedings. Where the jurisdiction of the court first seised is
37. Cf. Expandable Grafts Partnership v. Boston Scientific B.V. [1999] F.S.R. 353, 360.
However, see also the critical comments by P. MeierBeck, Aktuelle Fragen des
Patentverletzungsverfahrens, 1999 G.R.U.R. 379, at 380.
38. See supra note 3.
39. See supra note 3.
40. Jenard, Report on the Convention on Jurisdiction and the Enforcement of Judgements
in Civil and Commercial Matters, 1979 O.J. (C 59) 1, 39.
41. Cf. Case 144/86, Gubisch v. Palumbo, 1987 E.C.R. 4861. For details on the lis
pendens rule, see Pålsson, Lis Pendens under the Brussels and Lugano Conventions,
FESTSKRIFT TILL STIG STRÖMHOLM 709 (1997).
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established, any other court shall decline jurisdiction in favour of that
court.42 As to specific requisites of lis pendens under article 21 of the
Brussels Convention, it suffices here to add that the ECJ in Gubisch
v. Palumbo held with respect to the objective identity of the “same
cause of action” that its concept could not be restricted to mean two
claims that are entirely identical.43 Additionally, as long as the parties
are the same, it is immaterial that the positions of the parties as
plaintiff and defendant are reversed in the two actions.44 This has far
reaching consequences for litigating validity and infringement of
European patents. Suppose, for example, that potential infringer of a
European patent with designations of Belgium, France, Germany, the
Netherlands and the United Kingdom commenced proceedings in
Belgium, where apparently it takes some five years for a patent
infringement action to come to trial and another five years for appeal,
sought to establish that the national designations of the European
patent of the potential plaintiff in Belgium were invalid and not
infringed in France, Germany, or in Belgium. The courts in Germany,
or France would have to decline jurisdiction for any later filed action
on infringement of the German or French part of the European patent
between the same parties.45 Patent practitioners refer to forum
shopping of this type as “deploying the Belgian torpedos.” An
alternative discussed in intellectual property law journals is the
“Italian torpedo.” This torpedo is a means for preventing a patentee
from obtaining effective relief by starting litigation in a Brussels
Convention country, which is believed or hoped to have slow court
procedures.46 Consequently, the Court of Appeals of Düsseldorf
42. Moreover, article 22 is concerned with related actions, which are loosely related
actions that are brought in the courts of different states. Here, the court first seised may stay its
proceedings while actions are pending at first instance.
43. Accordingly, the Court held, it covers the case where a party brings an action before a
court in a Contracting State for the rescission or discharge of an international sales contract
while an action by the other party to enforce the same contract is pending before a court in
another Contracting State, [1987] E.C.R. 4861.
44. The Court of Appeal of Düsseldorf, following the Gubisch v. Palumbo ECJ decision,
however, held that there was no identity of the parties if in the pending Italian proceedings the
defendant was a subsidiary of the defendant before the German Court,
Kondensatorspeicherzellen [1998] G.R.U.R. 803 (Int.). For more details, see Pålsson, supra
note 40, at 717, with further references to the ECJ Case Law.
45. Cf. Sepracor Inc. v. Hoechst Marrion Roussel Ltd., [1999] F.S.R. 746.
46. Impfstoff [1998] G.R.U.R. 804. Cf. also Franzosi, M., Worldwide Patent Litigation
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stayed infringement proceedings under article 21 of the Brussels
Convention against a potential infringer of the German part of a
European patent. Earlier, the potential infringer had filed an action on
validity of the Belgian part of that European patent, while at the same
time also moving for a judgement of non-infringement in Germany
with the Tribunal de Première Instance in Brussels.47
The last Brussels Convention provision that is important to patent
litigation in this context is article 24, which shifts provisional and
protective measures outside the usual rules on jurisdiction. Under this
provision courts of a Contracting State may be approached for such
measures covered by the law of that state. This is true even if under
the Brussels Convention, the courts of another Contracting State have
jurisdiction over the substance of the matter. Two main questions
arise here. The first question is whether provisional and protective
measures under article 24 may be ordered if the order affects other
Contracting States. The second question is whether such orders are
fully enforceable in other Contracting States. As to the latter issue,
under the case law of the ECJ, a distinction is made between
protective interlocutory orders arising out of inter partes and ex parte
protective measures. Whereas the latter must be sought separately in
each state, enforceability of the former should be secured based on
the order.48 In Denilauler v. Couchet Frères the ECJ clarified that the
justification for the additional jurisdiction under article 24 lies in the
fact that the local courts are in the best position to judge the
circumstances affecting whether the requested measures are to be
allowed or refused.49 In view of this ratio of article 24, in Expandable
Grafts Partnership et al. v. Boston Scientific B.V. et al. the Hague
Court of Appeals  held that measures to be imposed under this
provision can be operative only within the territory of the state of the
court. According to the Dutch court it was irreconcilable with the
Denilauler v. Couchet Frères ruling of the ECJ “[t]hat a Dutch Court
which has jurisdiction exclusively by virtue of article 24, should issue
and the Italian Torpedo, [1997] EIPR, 382. 
47. Id.
48. Case 125/79, Denilauler v. Couchet Frères 1980 E.C.R. 553. Cf. also Dashwood,
supra note 13, at 140, with further references.
49. Id. para. 16.
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regulatory measures having effect abroad.”50 The UK Court of
Appeal pointed out that the measures at hand “must be provisional
and, in our view, granted in aid of or as an adjunct to some final
determination then in contemplation.”51 For the sake of clarity, the
Hague Court of Appeals, which found jurisdiction with respect to all
defendants including those domiciled outside the Netherlands based
not exclusively on article 24 but also on article 6(1) of the Brussels
Convention, advocated the view that it had jurisdiction over all
Boston Scientific Group Corporations regarding actions for interim
injunction against infringement of the foreign patents. The Hague
Court, however, refused such actions “[b]ecause the likelihood is that
the foreign patents will be declared null and void.”52 Thus, contrary
to the position of the British courts, which refuse to look into the
validity issue of foreign patents as soon as they have has been
challenged,53 the Dutch court feels adequately skilled to make its own
preliminary value judgement in this regard.
Although, in the 1970s, the Brussels Convention was
“discovered” as an apparently appropriate instrument to be applied in
the field of patent litigation, it was not until 1994 that it gained
practical importance in that field.54 On February 3, 1994,55 based on
articles 5(3) and 6(1) of the Brussels Convention, the Hague Court of
Appeals granted a so-called “cross-border patent prohibitory
injunction” for the infringement of a European patent granted for the
Netherlands, as well as for the Federal Republic of Germany, France,
Liechtenstein, Luxembourg, Austria, United Kingdom, Switzerland
and Sweden.56 The Hague decision has attracted enormous attention
and was a starting signal for entirely new case law under the Brussels
50. [1999] F.S.R. at 362.
51. Fort Dodge Animal Health Ltd. v. Akzo Nobel N.V., [1998] F.S.R. at 245.
52. [1999] F.S.R. at 362-63.
53. Coin Controls Ltd. v. Suzo International (U.K.) Ltd. [1997] F.S.R. 660, 677. Meier-
Beck, 1999 G.R.U.R. 379, at 380.
54. Cf., e.g. D. Stauder, Die Anwendung des EWG-Gerichtsstands- und
Vollstreckungsübereinkommens auf Klagen im gewerblichen Rechtsschutz und Urheberrecht,
1976 G.R.U.R. INT. 465, 510.
55. [1995] I.E.R. 8, German translation 1995 G.R.U.R. 253 (Int).
56. For a thorough analysis of that decision, cf. Bertrams, The Cross Border Prohibitory
Injunction in Dutch Patent Law, 26 I.I.C. 618 (1995).
https://openscholarship.wustl.edu/law_journal_law_policy/vol2/iss1/13
219.doc 08/24/00
2000] Patent Litigation in Europe 417
Convention. This occurred first in the Netherlands,57 then in
Germany,58 and eventually in the United Kingdom,59 the mother
country of the patent system. The current slowly began to revert
because the British courts convincingly demonstrated that, in their
understanding, no conclusion could be reached in a patent litigation
on infringement without consideration of the validity of the patent.
The British Courts thus touched upon the weakest point of the
Brussels Convention as applied to patent litigation.
First, the Court of Appeal of the United Kingdom explicitly
pointed out that for the purposes of article 19 of the Brussels
Convention an infringement claim covering acts carried out in the
United Kingdom is principally concerned with validity of the United
Kingdom patent; therefore, by reason of article 19 and article 16 of
the Brussels Convention, the claim falls within the exclusive
jurisdiction of the United Kingdom Court. It then concluded that:
[I]f the United Kingdom Courts have exclusive jurisdiction
over the dispute concerning the United Kingdom patent, then
there is no justification for the respondents attempting to
obtain from the Dutch Court even provisional relief as an aid
to or an adjunct of the claim for final relief in respect of the
United Kingdom patent. It would be vexatious to seek such
relief.60
The Court, however, accepted that a contrary opinion was also
tenable. Thus, the matter was not acte clair. It therefore referred a
number of questions, which were designed to the European Court of
Justice to elucidate how articles 6, 16(4), 19 and 24 should be
applied.61 Following the April 23, 1998 decision of the Hague Court
57. For an overview of the Dutch case law, see Gielen, Litigating Patents in the
Netherlands: Procedure and Cross-Border Effects; Where Do We Stand?, PATENT WORLD,
Dec. 1997/Jan. 1998, at 27; cf. also Coletti, No Relief in Sight: Difficulties in Obtaining
Judgements in Europe Using EPO Issued Patents, 1999 J.P.T.O.S. 351 359.
58. For the German case law, see P. von Rospatt, Entscheidungen deutscher Gerichte in
Patentverletzungsprozessen mit grenzüberschreitender Wirkung, 1997 G.R.U.R. INT. 861; and
P. Meier-Beck, 1999 G.R.U.R. 379.
59. Cf. Coin Limited v. Suzo International (U.K.) Limited [1997] F.S.R. 660; Fort Dodge
Animal Health Ltd. v. Akzo Nobel N.V. [1998] F.S.R. 222.
60. Fort Dodge Animal Health Ltd. v. Akzo Nobel N.V. [1998] F.S.R. 245, 246.
61. [1998] F.S.R. at 246.
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of Appeals in Expandable Grafts Partnership et al. v. Boston
Scientific B.V. et al., Dutch case law also experienced important
corrections, which are already partially reported on above.62
Given the foregoing analysis of the basic mechanisms of the
Brussels Convention, it seems difficult to claim that these
mechanisms have proven to be instruments that make patent litigation
in the Member States of the European Union or the European
Economy more efficient. In fact, the opposite appears to be true. In
Sepracor Inc. v. Hoechst Marrion Roussel Ltd. et al., Mr. Justice
Laddie bluntly characterized the system under the Brussels
Convention:
A less sensible system could not have been dreamt up by
Kafka. It does not meet the legitimate needs of patent holders
and potential infringers within EPC countries and simply
proliferates pre-emptive litigation. The fact that there is a
difference of opinion between the courts in various countries
as to the effect of the Brussels Convention has not caused the
problem, but it has exacerbated it. The sooner that difference is
resolved by the ECJ the better.63
Other judges seem to share this view. For instance, Mr. Justice
Brinkhoff, from the Hague Court of Appeals, has described the
situation as totally unacceptable. In his opinion, a revision of the
Brussels Convention could solve the problems. A better solution in
his understanding, however, would be a European patent court:
[C]ross-border patent dispute should be decided by “cross-
border” courts, i.e., courts composed of experienced judges
from different countries.64 Such court would provide a legal
62. See also J. Brinkhoff, Cross-Border Injunctions: Dead in the EU?, IP WORLD-WIDE,
Mar./Apr. 1999, at 3; von Maibom/Pitz, Die europäische “Transborder-rechtsprechung” stößt
an ihre Grenzen, 1998 G.R.U.R. INT. 765. Doubts as to the cross-border injunctions case law in
the Netherlands had been raised before, cf. Brinkhoff, Geht das grenzüberschreitende
Verletzungsverbot im niederländischen einstweiligen Verfügungsverfahren zu weit?, 1997
G.R.U.R. INT. 489.
63. [1999] F.S.R. at 352 (No. 14).
64. For example, other judges, such as Sir Robin Jacob, have even suggested that the
Enlarged Board of Appeal of the European Patent Office should be staffed by national judges
with patent experience and that the Board could go “on circuit” for the short periods necessary
(cf. Sir Robin Jacob, The Stephen Stewart Memorial Lecture: Industrial Property— Industry’s
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framework to match the existing economic and commercial
realities in Europe.65
III. THE EU GREEN PAPER AND ITS FOLLOW-UP
When compared with the level of economic and legal integration
in the European Union, characterized by the single currency and the
exhaustion of industrial property rights within the territory of the
Union, the area of European patent protection, in general, and that of
patent litigation, more specifically, must appear rather puzzling to the
neutral spectator.66 The obvious questions he or she might ask are:
How does the Community handle this issue? Do plans exist on the
part of the European Union aimed at improving the present state of
affairs or at introducing an entirely new system? What has happened
to the Convention for the European Patent for the Common Market
(Community Patent Convention— CPC) of 1975, as last adopted in
1989, in the context of the Agreement Relating to Community
Patents (ACP)? What happened to its “Protocol on the Settlement of
Litigation Concerning the Infringement and Validity of Community
Patents” (“The Protocol on Litigation,” POL)?67
The EU Commission eventually took the initiative and, on June
24, 1997, presented its “Green Paper on the Community Patent and
the Patent System in Europe.”68 It was much welcomed, but it is a shy
attempt to revitalize the mentioned Community instruments in the
patent field given the general level of integration reached in the union
in the meantime. The shyness is best demonstrated by the fact that,
despite the existence of the single market and the single currency, the
Commission sought advice from the interested circles regarding
Enemy?, [1997] I.P.Q. 1, 6).
65. J. Brinkhoff, IP WORLDWIDE, Mar./Apr. 1999, at 4-5. See also Antje Sedemund-
Treiber, Strukturen einer europäischen Patentgerichtsbarkeit, MITTEILUNGEN DER DEUTSCHEN
PATENTANWÄLTE 121, 125 (1999), where the President of the German Federal Patent Court is
pleading in the same direction.
66. For an overall characterization of the state of the European Patent System, see the
report prepared for the EU Commission by J. Straus, The Present State of the Patent System in
the European Union, Luxembourg 1997, at 5, with further references.
67. 1989 O.J. (L 401).
68. COM(97)314 final.
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whether a Community Patent was even needed.69
Even though the future of the Community Patent System proper is
not the topic of this paper, I wish to expressly maintain that, in view
of the actual stage of economic, political, and legal integration in the
Union, a unitary Community patent system covering all relevant
aspects including subject matter eligible for patent protection,
patentability requirements, patent granting procedure, effects of the
patents, infringement and validity, is a must. In fact, it is overdue
both politically and economically. This opinion has been formed by
the vast majority of those reacting to the Commission’s Green Paper,
which the European Parliament adopted on November 19, 1998, as a
Resolution on the Green Paper.70 The resolution stated inter alia that
the 1975 Luxembourg Convention and the 1989 Agreement relating
to Community patents, which has not come into effect, do not
provide unitary protection of patents within the European Union. The
European Parliament stated “[t]hat the Community patent must form
the subject of a Community regulation which has Article 235 of the
EC Treaty as its basis.” Furthermore, the European Patent Office, in
co-operation with national authorities, should be the technical
operator of the Community patent.71 With regard to the jurisdiction in
patent infringement or revocation actions, the European Parliament
advocated the view that: “the substance of such cases should be
examined by two national courts and that the European Court of
Justice should be the court which hears appeals on points of law.”72
69. The Heading Under  2.2 of the Green Paper, “The Need for Further Action on the
Community Patent,” reads:
The first question that needs to be addressed is whether and to what extent interested
parties would be prepared to use the Community patent system as devised in the
Luxembourg Convention if it were at last to come into effect following ratification by
the twelve Signatory States. Would industry be attracted towards the new system or
would, on the contrary, the existing system of the European Patent and national patents
prove sufficient to meet its needs? In the latter eventuality, use of the Community
Patent would be extremely limited, if not marginal.
Id. at 3. By the same logic the first question in this context reads: “Generally speaking, what
would in your view be the advantages and disadvantages of patent protection covering the
entire Community, in terms of . . . ” Id. at 6.
70. Also published in 1999 EPO O.J. 193.
71. 1999 EPO O.J. 193, 194.
72. Lit. K. 6 (1999 EPO O.J. 195). The Resolution of the European Parliament also
contains a number of other suggestions, inter alia, relating to the crucial language issue and the
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In the area of direct interest, namely court jurisdiction in validity
and patent infringement cases, the Green Paper remains modest.
Based on the assumption that, as provided under the Litigation
Protocol of 1989, infringement cases should remain in the jurisdiction
of national Community Courts, the Green Paper’s respective
questions were focused exclusively on validity. The Green Paper
envisioned “[e]xclusive jurisdiction for revocation proceedings to
bodies operating within the EPO (revocation division) and, on appeal,
the Court of First Instance of the European Communities,” or,
tentatively, “[j]urisdiction of national courts, whose decisions should
have effect in the territory of the Member State in which the court is
located.”73 Not surprisingly, the responses submitted to the
Commission went beyond the points raised. They unanimously
revealed that it was absolutely essential for infringement and validity
proceedings to be held together and tried by the same court at the
same time. The responses gave several reasons for this, including
cost, delay, and securing uniform interpretation as to the scope of the
claims. A significant number of respondents also rejected the idea of
referring revocation to the EPO, primarily because of the time
consuming procedure already experienced.74 As to the question of
which court should be the Community patent court of first instance,
the designated national courts or a common court, be it located in one
place or different divisions in different geographic areas, or being
peripatic, i.e. circuit court, the responses were less than clear. The
responses displayed a certain tendency to give preference to a
common court, however. No sympathy was expressed either for
revocation for a given Member State only, or for inter partes
invalidation. There was expressed, however, unanimity that for
appeals from first instance decision on infringement and validity of
Community patents jurisdiction should be with a single or common
court of appeal.75
After having considered the November 19, 1998 Resolution of the
costs, which cannot be discussed here.
73. COM(97)314 final, at 12.
74. Cf. CJA Consultants Ltd., Report on Responses to the European Commission Green
Paper on Promoting Innovation through Patents, 10 (June 1998).
75. Id. at 11.
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European Parliament and the results of hearings with interested
circles the Commission released on February 5, 1999 a
Communication to the Council, the European Parliament, and the
Economic and Social Committee,76 entitled “Promoting Innovation
Through Patents— The Follow-Up to the Green Paper on the
Community Patent and the Patent System in Europe.”77 According to
the Commission, the aim of this Communication was to announce the
various measures and new initiatives that the Comission planned to
take or propose in the future to make the patent system attractive for
promoting innovation in Europe.78
The Commission enumerated several actions that are urgent at the
Community level. The first is the preparation of a draft regulation on
Community patent based on article 235 EC in the course of 1999.
The next is the preparation of a proposal for a Directive based on
article 100A EC on the patentability of computer programs. The
Commission also called for provisions clarifying the role of patent
agents in the European Union. Furthermore, they mentioned both
launching a pilot action designed to back the efforts of national patent
offices to promote innovation and organizing a European conference
for exploring “legal protection” insurance for legal action in
connection with patents. The Commission also listed launching a
procedure for accession of the Community to the EPC and the
preparation of a communication from the Commission on better
dissemination of information on patent law among inventors,
researchers, and small and medium size enterprises. A study of
employees’ inventions and of the harmonization of the scope of
exceptions to the effects of patents in sectors that are required to have
prior authorization for market release have been announced as
medium-term actions.79
In this context the announced action of the Commission regarding
the preparation of a draft Regulation on Community patent is of
76. Doc. (COM 42)  (1999).
77. 1999 EPO O.J. 197.
78. No. 1.3 (1999 EPO O.J. 203,204).
79. Cf. The Summary of actions and recommendations in Urgent and Medium-term
actions at Community level, 1999 EPO O.J. 199. Note, however, that until February of 2000,
the Commission did not release any draft for a Community patent regulation or any other
communication.
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primary importance and is briefly addressed here. A decisive reason
for the Commission’s action was their overdue realization of the
perception that there existed a real need for a unitary Community
patent covering the entire territory of the European Community and
that in order to meet that need. The established system would need to
be more cohesive than the system that the Luxembourg Convention,
concluded in 1975 and revised in 1989, had envisaged. The
Commission added that it was the unanimous opinion of the users
that the Luxembourg Convention presents a major disadvantage in
exploiting the internal market of the Community as the “natural
market,” and therefore it is no longer in a position to guarantee the
necessary unitary protection.80 The main features of a Community
patent in the form of a Community Regulation based on article 235 of
the EC Treaty, therefore should be as follows: It must be a unitary
instrument, i.e. have same impact Community wide; it must be
affordable, i.e. cost about the same as a European patent covering a
limited number of countries; it must guarantee legal certainty; and it
should, at least for a transitional period, co-exist with the national and
the European patent, to which further improvements should be
made.81
The Communication remained somewhat unenlightened as to the
system to be proposed for guaranteeing legal certainty. On the one
hand it clearly stated that the system adopted in the Luxembourg
Convention, under which any national court deciding on patent
infringement where a counterclaim for revocation was made could
revoke the Community patent with effect throughout the Community,
was considered a major risk and a source of legal uncertainty. On the
other hand while not yet explicitly envisioned, the solution apparently
would entrust competence for deciding on revocation and
infringement regarding Community patents to a single court of First
Instance per Member State. The Commission did not express any
specific view as to which court(s) should act as an appeal court in the
Communication. Instead, it commented on the suggestions made by
the Economic and Social Committee of the European Parliament that
the national court of First Instance should only have competence to
80. Cf. No. 2.2 of the Communication (1999 EPO O.J. 205).
81. Cf. No. 2.3 of the Communication (1999 EPO O.J. 206-10).
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decide the validity inter partes. Moreover, it also mentioned the
recommendation of the European Parliament that two national courts
should rule on the substance with the ECJ acting as a court of
appeal,82 but added that these suggestions need to be studied in
greater depth.83 Some more recent statements of Officials of the EU
Commission, however, imply that the Commission gives some
preference to a scheme in which the jurisdiction for validity and
infringement would be at the first instance with a single court per
Member State and the Community Court of First Instance would hear
appeals on points of law.84
IV. INTERGOVERNMENTAL CONFERENCE OF EPO MEMBER STATES
It is an open question whether and when the plans that the EU
Commission envisioned with respect to the Community Patent
Regulation will materialize. Many hurdles, which in the past had
proven to be insurrmountable, will have to be overcome. First in line
among those is the translation issue. Even if the EU Member States
would eventually prove that they have matured enough to
compromise, a Community Patent Regulation could not solve the
present problem of patent litigation for many decades. This is
because it would not affect the many hundred thousands of European
patents already issued or those that will be issued in the future under
the EPC. To master the “Kafka scenario” controlled by the Brussels
Convention, other means are necessary and, at last, are being sought.
On June 24 and 25, 1999 an Intergovernmental Conference of the
Member States of the European Patent Organization on the reform of
the patent system in Europe took place in Paris.85 This Conference,
inter alia, considered the European patent litigation situation and
concluded it was necessary “[t]o increase the effectiveness and legal
certainty of the protection conferred by the European patent by
establishing a jurisdictional system that meets the need for a uniform
82. See also supra note 25.
83. Cf. No. of the Communication 2.3 (1999 EPO O.J. 208).
84. October 1999 lecture given by Mr. Noteboom at the Patinnova ‘99 Congress in
Chalkidiki, Greece.
85. Cf. 1999 EPO O.J. 545.
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interpretation of the European Patent.”86 The Conference therefore
recommended that the Contracting States, to the extent possible,
provide for a concentration of courts dealing with patent litigation
and with the help of the EPO provide for the training of judges.
Moreover, the conference mandated a working party chaired jointly
by Germany, Luxembourg, and Switzerland to present inter alia
before July 1, 2000 “[a] draft text for an optional protocol to the EPC
which, with regard to litigation concerning European patents, would
commit its signatory states to an integrated judicial system, including
uniform rules of procedure and a common Court of Appeal.”87
In the meantime, the Working Party has met on several occasions,
but little has leaked to the public on the results achieved. One
therefore should not succumb to the temptation to speculate too
much. The date that the group must deliver its draft text is
approaching quickly. It is clear from the mandate itself that the
envisaged integrated judicial system should be optional and should be
headed by a Common Court of Appeal; moreover, the system should
have uniform rules of procedure. Thus, not too many alternatives
remain open as to the structure. One decision among those
alternatives is whether the Competent Court of First Instance should
be a national or a European-central court. Past experience suggests
that the competence of national patent courts, even if only one single
court per EPC Contracting State is appointed, should not be viewed
as a very realistic or acceptable alternative to the multinational
industry. Also, as clearly revealed by the responses to the EU Green
Paper, neither a separation of revocation and infringement
proceedings, nor any involvement of the EPO in revocation
proceedings appear acceptable. The responses given to the EU Green
Paper are equally valid in reference to the issue at hand, namely an
integrated judicial system under the EPC.88
In view of the complexity of patent litigation, which can hardly
find a similarly complex counterpart in other areas of law due to its
86. Id. para. 2.
87. Id. at 548. The other two tasks mandated are: a study relating to conditions under
which arbitration might be acknowledged by the Contracting States in validity and infringement
litigation, and a search for the term to establish and finance a common advisory entity to which
national jurisdiction could refer when seeking advise relating to validity and infringement.
88. See supra note 26.
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inseparable link to technology, new opportunities should be available
to examine the substance of the cases. Furthermore, there should also
be an opportunity to hear appeals on points of law. In this latter
regard, an interesting suggestion was made by Dr. Messerli, Vice-
President of the EPO and Chairman of the Enlarged Board of Appeal,
in his presentation at the International Patent Appeal Examination
Symposium in Tokyo.89 Dr. Messerli developed a scheme for an
entirely integrated European patent jurisdiction. On one side, the
scheme places European or National Patent Courts of First Instance,
having jurisdiction on infringement and revocation of European
patents, with a possibility to appeal to a Common European Patent
Court of Second Instance. On the other side, it places the existing
patent granting structure of the EPO, including Boards of Appeal.
This structure should be headed by a Supreme European Patent
Court, which would hear appeals on points of law filed from the
decisions of the European Patent Court of Second Instance, as well as
from decisions of the Boards of Appeal of the EPO. In the
understanding of Dr. Messerli, the Enlarged Boards of Appeal should
be merged into this Supreme European Patent Court. It is generally
understood that the European Patent Court should be staffed by
judges experienced in patent matters. In view of the positive
experience with the Federal Patent Court in Germany, those in
Germany who have addressed the future jurisdiction scheme in
Europe have understandably advocated the view that the patent courts
dealing with the substance of cases should be composed of lawyers
and technical members.90 Since lawyers in Europe, unlike their
colleagues in the USA, generally lack any technical education, this
fact is of particular concern. A situation that allows for experts
appointed by the court to eventually decide the case should be
avoided.91 As to which rules of procedure to apply, the Working
Group drafting the text of the Protocol could find many solutions in
the Agreement on the Community Patent and its Protocol on
89. Organized by the Japanese Patent Office, on November 19th and 20th, 1998.
90. Cf. A. SEDEMUND-TREIBER, MITTEILUNGEN DER DEUTSCHEN PATENTANWÄLTE 125
(1999); M. Rau, Wie soll ein gerichtliches Patentschutzsystem in Europa neben den nationalen
Gerichten unter besonderer Berücksichtigung des “Grünbuch-Gemeinschaftspatents EU”
aussehen? MITTEILUNGEN DER DEUTSCHEN PATENTANWÄLTE 241, 242 (1998).
91. Cf. M. RAU, MITTEILUNGEN DER DEUTSCHEN PATENTANWÄLTE 242 (1998).
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Litigation of 1989, which have been generally accepted in the past.
Of course, an optional Protocol to the EPC does not appear to be a
final solution for litigating European patents. This is especially true
for European patents with the designation of the Member States of
the European Union. If the Protocol would be signed and ratified by
only a limited number of the EU Member States. The Community
and its single market would then be divided into two classes; the first
class being those controlled by the Protocol forming a truly single
market, and the other class being those within the single market,
which would remain outside. Such a situation might be acceptable
temporarily but cannot constitute a lasting solution. It therefore
should be envisioned and possibly set forth in a Resolution to be
adopted in parallel to the adoption of the Protocol that, as soon as a
certain number of EU Member States have become party to the
Protocol, article Vd of the 1978 Protocol to the Brussels Convention,
or a legal instrument of the European Union succeeding the Brussels
Convention, should be revised to read: “Without prejudice to the
jurisdiction of the EPO under the EPC . . . , the European Patent
Courts as provided for under the Protocol to the EPC shall have
exclusive jurisdiction, regardless of domicile, in proceedings
concerned with registration or validity, as well as with infringement
of any European patent.” Once such a revision of the Protocol to the
Brussels Convention has been completed, that scheme could be
entirely applied under the future Community Patent Regulation.
V. CONCLUDING REMARKS
Is there a glimmer of hope that Europe will, within foreseeable
time, get an integrated system for litigating European patents, or do
we have to agree with Coletti, who recently titled his JPTOS
contribution “No Relief In Sight”?92 Past experience calls for caution
and contained optimism, but optimism nevertheless. The June 1999
Intergovernmental Conference of the Member States of the European
Patent Organization and its mandated tasks, as well as the clear
evidence that the Brussels Convention scheme in its present form
does not solve the problems put pressure on the EPC Contracting
92. See supra note 54.
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States as well as on the EU Commission and other responsible organs
of the European Union. During the past two years, the latter have
finally left the stage of dormancy to become active. Moreover, the
prospects of enlarging the number of the EPC Contracting States by
the year 2002 and the subsequent or parallel enlargement of the
Community should remove even the last remaining hesitations,
spurring on the ability to compromise that is already present at this
point in time. Otherwise, even more unexperienced courts and judges
will enrich the already busy landscape of European patent litigation.
The first step in the right direction should be an optional Protocol to
the EPC, which should lead Europe to an institution modelled after
the most successful U.S. Court of Appeal for the Federal Circuit. The
fact that the European Union is not a Federal State should not be an
annoyance.
Finally, there is another possibility of central revocation of
European patents that only affects the parties. In June 1999 the U.S.
Delegation at the Hague Conference on Private International Law
preparing a preliminary Convention on jurisdiction and the effects of
judgements in civil and commercial matters (a Convention that
corresponds to the Brussels Convention at universal level) proposed
that courts having jurisdiction over a defendant should also have
competence to make determinations concerning the status or validity
of the deposit or registration of, inter alia, patents, with effect only
on the parties.93 No matter how attractive for United States lawyers
the prospect of litigating the validity of a European patent may be, I
do not believe that this would solve our problems or lower the cost of
patent litigation. This type of conflict resolution should be reserved
for arbitration, which is controlled by mutual agreement of the parties
involved. Under all circumstances a European CAFC would be
preferable.
93. Hague Conference on Private International Law, Work, Doc. 241.
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